| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 20 | 2018 | 195 | 2.280 |
Why?
|
| Brain | 17 | 2020 | 965 | 2.260 |
Why?
|
| Alcohol Drinking | 11 | 2018 | 255 | 1.620 |
Why?
|
| Central Nervous System Depressants | 11 | 2017 | 63 | 1.080 |
Why?
|
| Alcoholism | 7 | 2016 | 97 | 0.820 |
Why?
|
| Animals | 43 | 2020 | 8199 | 0.670 |
Why?
|
| Macaca mulatta | 17 | 2019 | 340 | 0.620 |
Why?
|
| Brain Mapping | 5 | 2014 | 190 | 0.560 |
Why?
|
| Self Administration | 15 | 2018 | 382 | 0.530 |
Why?
|
| Tissue Banks | 2 | 2014 | 14 | 0.520 |
Why?
|
| Macaca fascicularis | 17 | 2020 | 542 | 0.500 |
Why?
|
| Radiopharmaceuticals | 4 | 2020 | 95 | 0.470 |
Why?
|
| Positron-Emission Tomography | 5 | 2020 | 171 | 0.470 |
Why?
|
| Neural Pathways | 2 | 2015 | 112 | 0.450 |
Why?
|
| Endocrine Glands | 1 | 2014 | 2 | 0.430 |
Why?
|
| Magnetoencephalography | 2 | 2017 | 12 | 0.420 |
Why?
|
| Liver | 2 | 2014 | 492 | 0.400 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 35 | 0.390 |
Why?
|
| Nerve Net | 1 | 2013 | 137 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2015 | 1223 | 0.350 |
Why?
|
| Somatosensory Cortex | 1 | 2009 | 30 | 0.290 |
Why?
|
| Male | 26 | 2020 | 19437 | 0.290 |
Why?
|
| Pregnanolone | 2 | 2017 | 3 | 0.250 |
Why?
|
| Carbon Radioisotopes | 4 | 2020 | 21 | 0.250 |
Why?
|
| Neurons | 5 | 2015 | 486 | 0.250 |
Why?
|
| Amygdala | 3 | 2015 | 60 | 0.230 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2019 | 35 | 0.220 |
Why?
|
| Receptors, GABA-A | 3 | 2013 | 32 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2014 | 232 | 0.200 |
Why?
|
| Cocaine | 5 | 2006 | 354 | 0.200 |
Why?
|
| Dopamine Uptake Inhibitors | 3 | 2012 | 147 | 0.180 |
Why?
|
| Microtubules | 2 | 2020 | 18 | 0.180 |
Why?
|
| Haplorhini | 4 | 2019 | 75 | 0.170 |
Why?
|
| Cocaine-Related Disorders | 3 | 2012 | 125 | 0.170 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 1083 | 0.170 |
Why?
|
| Quinazolines | 1 | 2020 | 35 | 0.160 |
Why?
|
| Synapses | 2 | 2011 | 87 | 0.150 |
Why?
|
| Morpholines | 1 | 2019 | 47 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 90 | 0.150 |
Why?
|
| Triazoles | 1 | 2019 | 15 | 0.150 |
Why?
|
| Dimethoxyphenylethylamine | 1 | 2019 | 2 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2019 | 77 | 0.140 |
Why?
|
| SNARE Proteins | 1 | 2018 | 3 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2019 | 87 | 0.140 |
Why?
|
| Primates | 2 | 2017 | 128 | 0.140 |
Why?
|
| Alcohol-Related Disorders | 1 | 2017 | 21 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2017 | 39 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 48 | 0.130 |
Why?
|
| Alcoholic Intoxication | 1 | 2017 | 28 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2017 | 75 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 29 | 0.120 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 3 | 0.120 |
Why?
|
| Acetaldehyde | 1 | 2016 | 4 | 0.120 |
Why?
|
| DNA Adducts | 1 | 2016 | 15 | 0.120 |
Why?
|
| Dopamine | 2 | 2012 | 262 | 0.120 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 30 | 0.120 |
Why?
|
| Corpus Striatum | 4 | 2004 | 69 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 2 | 2016 | 82 | 0.120 |
Why?
|
| Septal Nuclei | 1 | 2015 | 16 | 0.110 |
Why?
|
| Sertraline | 1 | 2015 | 27 | 0.110 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2015 | 41 | 0.110 |
Why?
|
| Electrophysiology | 2 | 2013 | 76 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2015 | 74 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2015 | 69 | 0.110 |
Why?
|
| Behavior, Animal | 7 | 2015 | 299 | 0.110 |
Why?
|
| Female | 12 | 2019 | 19942 | 0.110 |
Why?
|
| Specimen Handling | 1 | 2014 | 30 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 478 | 0.110 |
Why?
|
| Computational Biology | 1 | 2014 | 99 | 0.100 |
Why?
|
| Cerebellum | 1 | 2013 | 25 | 0.100 |
Why?
|
| Putamen | 2 | 2011 | 28 | 0.100 |
Why?
|
| Neural Conduction | 1 | 2013 | 82 | 0.100 |
Why?
|
| Craniotomy | 1 | 2013 | 38 | 0.100 |
Why?
|
| Methylphenidate | 1 | 2012 | 36 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2015 | 349 | 0.090 |
Why?
|
| Olivary Nucleus | 1 | 2011 | 4 | 0.090 |
Why?
|
| Algorithms | 1 | 2014 | 536 | 0.090 |
Why?
|
| Prefrontal Cortex | 2 | 2010 | 85 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 53 | 0.090 |
Why?
|
| Biolistics | 1 | 2010 | 1 | 0.080 |
Why?
|
| Mice | 4 | 2019 | 2571 | 0.080 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 84 | 0.080 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2010 | 12 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 90 | 0.080 |
Why?
|
| Autoradiography | 4 | 2019 | 51 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 193 | 0.080 |
Why?
|
| Hippocampus | 1 | 2011 | 216 | 0.080 |
Why?
|
| Dissection | 1 | 2009 | 16 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 637 | 0.070 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2009 | 7 | 0.070 |
Why?
|
| Postmenopause | 1 | 2011 | 424 | 0.070 |
Why?
|
| Deoxyglucose | 2 | 2006 | 12 | 0.070 |
Why?
|
| Fingers | 1 | 2009 | 75 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2009 | 135 | 0.070 |
Why?
|
| Receptors, Dopamine | 2 | 2012 | 26 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 420 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 114 | 0.060 |
Why?
|
| Limbic System | 2 | 2004 | 15 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 114 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 155 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 717 | 0.060 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2006 | 8 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2006 | 34 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 314 | 0.060 |
Why?
|
| Thalamus | 1 | 2006 | 36 | 0.060 |
Why?
|
| Calcium Channels, T-Type | 1 | 2006 | 28 | 0.060 |
Why?
|
| Sleep Deprivation | 1 | 2005 | 12 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2005 | 16 | 0.060 |
Why?
|
| Nootropic Agents | 1 | 2005 | 13 | 0.060 |
Why?
|
| Wakefulness | 1 | 2005 | 25 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Stem Cells | 1 | 2007 | 321 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 89 | 0.050 |
Why?
|
| Neostriatum | 1 | 2004 | 28 | 0.050 |
Why?
|
| Models, Psychological | 1 | 2004 | 25 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2003 | 39 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 3 | 2011 | 76 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 85 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 2204 | 0.050 |
Why?
|
| Organ Size | 2 | 2015 | 221 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 345 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2013 | 18 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2010 | 499 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2011 | 76 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 543 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 90 | 0.040 |
Why?
|
| Glucose | 3 | 2006 | 160 | 0.040 |
Why?
|
| Rats | 2 | 2019 | 1895 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2019 | 4 | 0.040 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 22 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2019 | 64 | 0.040 |
Why?
|
| Papio | 1 | 2019 | 78 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2017 | 1 | 0.030 |
Why?
|
| Action Potentials | 2 | 2011 | 212 | 0.030 |
Why?
|
| Calcium Signaling | 2 | 2010 | 49 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 21 | 0.030 |
Why?
|
| Macaca | 1 | 2017 | 30 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 18 | 0.030 |
Why?
|
| Calcineurin | 1 | 2017 | 3 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2017 | 4 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2017 | 7 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2017 | 8 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 897 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 81 | 0.030 |
Why?
|
| Methamphetamine | 1 | 2016 | 20 | 0.030 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2016 | 23 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 124 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 83 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 40 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 143 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 90 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 69 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 2015 | 23 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 543 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2015 | 31 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2015 | 19 | 0.030 |
Why?
|
| Hormones | 1 | 2015 | 24 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 33 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 454 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 200 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 247 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 124 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2015 | 58 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 276 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 8 | 0.030 |
Why?
|
| Pyridazines | 1 | 2013 | 8 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 362 | 0.030 |
Why?
|
| Anxiety | 1 | 2015 | 190 | 0.030 |
Why?
|
| Memory, Short-Term | 2 | 2005 | 61 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2006 | 413 | 0.030 |
Why?
|
| Extinction, Psychological | 2 | 2004 | 17 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 821 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 82 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2012 | 13 | 0.020 |
Why?
|
| Growth | 1 | 2012 | 7 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 33 | 0.020 |
Why?
|
| Humans | 3 | 2019 | 32274 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 2012 | 122 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 112 | 0.020 |
Why?
|
| Tungsten | 1 | 2010 | 2 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 285 | 0.020 |
Why?
|
| Dendrites | 1 | 2010 | 17 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 74 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 46 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2010 | 11 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 26 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 44 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 60 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2010 | 35 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 621 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 168 | 0.020 |
Why?
|
| Immunochemistry | 1 | 2007 | 8 | 0.020 |
Why?
|
| Blood Cells | 1 | 2007 | 9 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2007 | 29 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 47 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 3416 | 0.020 |
Why?
|
| Flunitrazepam | 1 | 2007 | 3 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 183 | 0.020 |
Why?
|
| GABA Modulators | 1 | 2007 | 9 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 13 | 0.020 |
Why?
|
| Isoprostanes | 1 | 2007 | 3 | 0.020 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2007 | 6 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 54 | 0.020 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2007 | 10 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 10 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2007 | 99 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2007 | 193 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2007 | 70 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 163 | 0.010 |
Why?
|
| Triglycerides | 1 | 2007 | 235 | 0.010 |
Why?
|
| Reinforcement Schedule | 1 | 2006 | 103 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 109 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 152 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 839 | 0.010 |
Why?
|
| Cholesterol | 1 | 2007 | 262 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 471 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 255 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 93 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 383 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 76 | 0.010 |
Why?
|
| Association | 1 | 2004 | 5 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 2004 | 29 | 0.010 |
Why?
|
| Time | 1 | 2004 | 27 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 246 | 0.010 |
Why?
|
| Quinpirole | 1 | 2003 | 16 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 94 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2003 | 30 | 0.010 |
Why?
|
| Mediodorsal Thalamic Nucleus | 1 | 2002 | 5 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2002 | 18 | 0.010 |
Why?
|
| Ventral Tegmental Area | 1 | 2002 | 35 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 144 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 591 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2002 | 80 | 0.010 |
Why?
|